OrbiMed’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-78,500
Closed -$1.94M 110
2024
Q4
$1.94M Buy
+78,500
New +$1.94M 0.04% 97
2020
Q3
Sell
-354,575
Closed -$8.63M 147
2020
Q2
$8.63M Buy
354,575
+175,075
+98% +$4.26M 0.12% 103
2020
Q1
$2.79M Buy
+179,500
New +$2.79M 0.05% 117